Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Breast Neoplasms 2Pancreatic Neoplasms 1Non-alcoholic Fatty Liver Disease 1Lung Neoplasms 1Insulin Resistance 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Metformin 149Clomiphene 51Letrozole 39Inositol 34Folic Acid 18Exercise 17Progesterone 15Ethinyl Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Estradiol 12Contraceptives, Oral 11cetrorelix 10Pioglitazone 10High-Intensity Interval Training 10Tablets 9Spironolactone 9Cholecalciferol 9Triptorelin Pamoate 8Diet 8Vitamin D 7Thioctic Acid 7Menotropins 7Liraglutide 7Acupuncture Therapy 7drospirenone 6Ovidrel 6Gonadotropins 6Flutamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Polycystic Ovary Syndrome × Canagliflozin × Clear all
NCT06256289 2024-02-13

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

The First Affiliated Hospital of Shanxi Medical University

Phase 4 Unknown
50 enrolled

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

NCT04700839 2022-09-10

PCOS

Shanghai 10th People's Hospital

Phase 4 Completed
68 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡